Leonard Green & Partners, L.P. Bria Cell Therapeutics Corp. Transaction History

Leonard Green & Partners, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$4.28 - $11.9 $2.14 Million - $5.95 Million	-500,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.91 - $10.14 $2.96 Million - $5.07 Million	500,000 New	500,000 $5.07 Million

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $17.7M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Leonard Green & Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Leonard Green & Partners, L.P. with notifications on news.